Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Alzheimer's Disease

  Free Subscription


16.10.2023

1 Acta Neuropathol
1 Alzheimer Dis Assoc Disord
11 Alzheimers Dement
1 Am J Geriatr Psychiatry
2 Ann Neurol
1 BMJ
2 Dement Geriatr Cogn Disord
1 Exp Gerontol
8 J Alzheimers Dis
1 J Am Geriatr Soc
1 J Neural Transm (Vienna)
1 J Neurochem
1 J Neurosci
2 Neurobiol Aging
1 Neurochem Res
2 Neurology
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neuropathol

  1. VANDEVREDE L, La Joie R, Horiki S, Mundada NS, et al
    Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab.
    Acta Neuropathol. 2023;146:777-781.
    PubMed        


    Alzheimer Dis Assoc Disord

  2. CLARK LR, Erickson CM, Chin NA, Basche KE, et al
    Anticipated Psychological or Behavioral Reactions to Learning Alzheimer Biomarker Results: Associations With Contextual Factors.
    Alzheimer Dis Assoc Disord. 2023 Oct 12. doi: 10.1097/WAD.0000000000000586.
    PubMed         Abstract available


    Alzheimers Dement

  3. RAN S, Lin X, Liu B
    A Mendelian randomization study of Alzheimer's disease and daytime napping.
    Alzheimers Dement. 2023 Oct 12. doi: 10.1002/alz.13505.
    PubMed        

  4. LI P, Gao L, Dashti HS, Hu K, et al
    Authors' response to: A Mendelian randomization study of Alzheimer's disease and daytime napping.
    Alzheimers Dement. 2023 Oct 12. doi: 10.1002/alz.13504.
    PubMed        

  5. SCOYNI F, Giudice L, Vaananen MA, Downes N, et al
    Alzheimer's disease-induced phagocytic microglia express a specific profile of coding and non-coding RNAs.
    Alzheimers Dement. 2023 Oct 12. doi: 10.1002/alz.13502.
    PubMed         Abstract available

  6. FERRANTE FJ, Migeot J, Birba A, Amoruso L, et al
    Multivariate word properties in fluency tasks reveal markers of Alzheimer's dementia.
    Alzheimers Dement. 2023 Oct 12. doi: 10.1002/alz.13472.
    PubMed         Abstract available

  7. GAIKWAD S, Senapati S, Haque MA, Kayed R, et al
    Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies.
    Alzheimers Dement. 2023 Oct 9. doi: 10.1002/alz.13490.
    PubMed         Abstract available

  8. WANG J, Sims KD, Ackley SF, Chen R, et al
    Association of cancer history with structural brain aging markers of Alzheimer's disease and related dementias risk.
    Alzheimers Dement. 2023 Oct 9. doi: 10.1002/alz.13497.
    PubMed         Abstract available

  9. NUDELMAN KNH, Jackson T, Rumbaugh M, Eloyan A, et al
    Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohort.
    Alzheimers Dement. 2023 Oct 6. doi: 10.1002/alz.13482.
    PubMed         Abstract available

  10. WANG M, Sajobi TT, Hogan DB, Ganesh A, et al
    Expert elicitation of risk factors for progression to dementia in individuals with mild cognitive impairment.
    Alzheimers Dement. 2023;19:4542-4548.
    PubMed         Abstract available

  11. KWON HS, Kim JY, Koh SH, Choi SH, et al
    Predicting cognitive stage transition using p-tau181, Centiloid, and other measures.
    Alzheimers Dement. 2023;19:4641-4650.
    PubMed         Abstract available

  12. BEYDOUN HA, Beydoun MA, Meirelles O, Erickson LD, et al
    Cardiovascular health, infection burden, and incident dementia in the UK Biobank.
    Alzheimers Dement. 2023;19:4475-4487.
    PubMed         Abstract available

  13. GONZALEZ-ORTIZ F, Dias A, Turton M, Magalhaes R, et al
    Preanalytical stability of plasma/serum brain-derived tau.
    Alzheimers Dement. 2023;19:4764-4770.
    PubMed         Abstract available


    Am J Geriatr Psychiatry

  14. JOE E, Segal-Gidan F, Cummings JL, Galasko D, et al
    Association Between Self- and Proxy-Reported Depression and Quality of Life in Mild-Moderate Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2023 Aug 24:S1064-7481(23)00389.
    PubMed         Abstract available


    Ann Neurol

  15. GRILL JD, Flournoy C, Dhadda S, Ernstrom K, et al
    Eligibility rates among racially and ethnically diverse US participants in Phase 2 and Phase 3 placebo-controlled, double-blind, randomized trials of lecanemab and elenbecestat in early Alzheimer's disease.
    Ann Neurol. 2023 Oct 13. doi: 10.1002/ana.26819.
    PubMed         Abstract available

  16. DARK HE, Paterson C, Daya GN, Peng Z, et al
    Proteomic indicators of health predict Alzheimer's disease biomarker levels and dementia risk.
    Ann Neurol. 2023 Oct 6. doi: 10.1002/ana.26817.
    PubMed         Abstract available


    BMJ

  17. DALY TP
    Informing consent to antibodies in Alzheimer's disease.
    BMJ. 2023;383:p2350.
    PubMed        


    Dement Geriatr Cogn Disord

  18. RICHTER AL, Diepeveen-de Bruin M, Balvers MGJ, De Groot LCPGM, et al
    Association between low vitamin D status, serotonin and clinico-bio-behavioral parameters in Alzheimer's disease.
    Dement Geriatr Cogn Disord. 2023 Oct 6. doi: 10.1159/000534492.
    PubMed         Abstract available

  19. CUSTODIO N, Malaga M, Montesinos R, Chambergo-Michilot D, et al
    The Memory Alteration Test is correlated with clinical, cerebrospinal fluid, and brain imaging markers of Alzheimer disease in Lima, Peru.
    Dement Geriatr Cogn Disord. 2023 Oct 12. doi: 10.1159/000534157.
    PubMed         Abstract available


    Exp Gerontol

  20. SUN J, Zhang Z, Yang K, Wei G, et al
    Ameliorative effects of pine nut peptide-zinc chelate (Korean pine) on a mouse model of Alzheimer's disease.
    Exp Gerontol. 2023 Oct 9:112308. doi: 10.1016/j.exger.2023.112308.
    PubMed         Abstract available


    J Alzheimers Dis

  21. KETCHUM FB, Erickson CM, Basche KE, Chin NA, et al
    Informing Disclosure: Efficacy of a Brief Educational Intervention on Research Participants' Knowledge about Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230732.
    PubMed         Abstract available

  22. BREDESEN DE, Toups K, Hathaway A, Gordon D, et al
    Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications.
    J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230467.
    PubMed         Abstract available

  23. GONZALEZ-MADRID A, Calfio C, Gonzalez A, Luttges V, et al
    Toward Prevention and Reduction of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230454.
    PubMed         Abstract available

  24. KIM M, Yi D, Byun MS, Ahn H, et al
    Development of a Cognitive Composite for Preclinical Alzheimer's Disease in Korean Older Adults.
    J Alzheimers Dis. 2023 Oct 5. doi: 10.3233/JAD-230263.
    PubMed         Abstract available

  25. LIU Y, Shen Y
    Applications of Nanoparticles in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230098.
    PubMed         Abstract available

  26. UKRAINTSEVA S, Duan M, Simanek AM, Holmes R, et al
    Vaccination Against Pneumonia May Provide Genotype-Specific Protection Against Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230088.
    PubMed         Abstract available

  27. LIU CC, Wang QH, Xin JY, Liu YH, et al
    Association of Adipokines with Alzheimer's Disease in a Chinese Cohort.
    J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-220860.
    PubMed         Abstract available

  28. BARBA L, Otto M, Abu-Rumeileh S
    The Underestimated Relevance of Alzheimer's Disease Copathology in Amyotrophic Lateral Sclerosis.
    J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230900.
    PubMed         Abstract available


    J Am Geriatr Soc

  29. BURKE LG, Burke RC, Duggan CE, Figueroa JF, et al
    Trends in healthy days at home for Medicare beneficiaries using the emergency department.
    J Am Geriatr Soc. 2023;71:3122-3133.
    PubMed         Abstract available


    J Neural Transm (Vienna)

  30. CANNAVACCIUOLO A, Paparella G, Salzillo M, Colella D, et al
    Facial emotion expressivity in patients with Parkinson's and Alzheimer's disease.
    J Neural Transm (Vienna). 2023 Oct 7. doi: 10.1007/s00702-023-02699.
    PubMed         Abstract available


    J Neurochem

  31. SAMUELS JD, Lukens JR, Price RJ
    Emerging roles for ITAM and ITIM receptor signaling in microglial biology and Alzheimer's disease-related amyloidosis.
    J Neurochem. 2023 Oct 11. doi: 10.1111/jnc.15981.
    PubMed         Abstract available


    J Neurosci

  32. BHEMBRE N, Bonthron C, Opazo P
    Synaptic Compensatory Plasticity in Alzheimer's Disease.
    J Neurosci. 2023;43:6833-6840.
    PubMed         Abstract available


    Neurobiol Aging

  33. XIA Y, Maruff P, Dore V, Bourgeat P, et al
    Longitudinal trajectories of basal forebrain volume in normal aging and Alzheimer's disease.
    Neurobiol Aging. 2023;132:120-130.
    PubMed         Abstract available

  34. HONEA RA, Hunt S, Lepping RJ, Vidoni ED, et al
    Alzheimer's disease cortical morphological phenotypes are associated with TOMM40'523-APOE haplotypes.
    Neurobiol Aging. 2023;132:131-144.
    PubMed         Abstract available


    Neurochem Res

  35. SASIDHARAN R, Mohanan R, Kukreti N, Raj P, et al
    MAO-B Inhibitor (2E)-3-(4-Bromophenyl)-1-(1H-indol-3-yl) prop-2-en-1-one as a Neuroprotective Agent Against Alzheimer's Disease.
    Neurochem Res. 2023 Oct 9. doi: 10.1007/s11064-023-04031.
    PubMed         Abstract available


    Neurology

  36. GOODSMITH MS, Wroblewski KE, Schumm LP, McClintock MK, et al
    Association of APOE epsilon4 Status With Long-term Declines in Odor Sensitivity, Odor Identification, and Cognition in Older US Adults.
    Neurology. 2023;101:e1341-e1350.
    PubMed         Abstract available

  37. SANTAMARIA BA, Corroza J, Sanchez-Ruiz de Gordoa J, Cabello C, et al
    Association of Blood-Based DNA Methylation Markers With Late-Onset Alzheimer Disease: A Potential Diagnostic Approach.
    Neurology. 2023 Oct 12:10.1212/WNL.0000000000207865.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  38. ABSKHARON R, Pan H, Sawaya MR, Seidler PM, et al
    Structure-based design of nanobodies that inhibit seeding of Alzheimer's patient-extracted tau fibrils.
    Proc Natl Acad Sci U S A. 2023;120:e2300258120.
    PubMed         Abstract available

  39. LIM CM, Gonzalez Diaz A, Fuxreiter M, Pun FW, et al
    Multiomic prediction of therapeutic targets for human diseases associated with protein phase separation.
    Proc Natl Acad Sci U S A. 2023;120:e2300215120.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.